A Comparison Between Oral Melatonin With Nasal Sevoflurane Versus Oral Chloral Hydrate With Nasal Sevoflurane in Sedation of Children Undergoing Brain MRI
NCT06606899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-11-20
Summary
The patients will be randomized into 2 equal groups by a computer-generated random numbers table, named group A, B.
Group A: will receive oral Melatonin and nasal Sevoflurane. Group B: will receive oral Chloral Hydrate and nasal Sevoflurane. In group A, Approximately 45 to 60 min prior to the intended scan time, the children will be given syrup melatonin 3 mg. Before starting the MRI scan, nasal sevoflurane will be started after positioning of the child at a concentration of 1%.
In Group B, the child will receive oral chloral hydrate (50 mg/kg, maximum 2 g) in syrup form was given to patients requiring sedation. Before starting the MRI scan, nasal sevoflurane will be started after positioning of the child at a concentration of 1% and will be increased gradually as needed to achieve adequate level of sedation.
The child will wait on a general hospital bed in a darkened room with its parents/carers at the rest room. When the radiology technicians decide; the child could be scanned, the child will then be transported in the arms of the parents/carers. Prior to entering the scanning room, the children and parents/carers will be checked for metal to ensure safe entrance. The child will then be lifted from the bed onto the MRI scanning table. Children will be scanned with headphones. If children did not fall asleep or if they woke up.
The MRI scan will be started. After the scanning procedure, the child and its parents/carers will be allowed to go home if the child feels well. All scans will be done on a 1.5 Tesla MR system, using a regular head coil. The MRI studies will be performed during daytime, the protocol duration will range from approximately 10 to 30 min, including positioning of the patient on the scan table. In case children move, radiology technicians could pause the study till the patients is adequately sedated and stops movement. An MRI scan will be considered to have failed when; the entire MRI scan was not assessable because of movement or in the presence of moved scans
Conditions
- Sedation for Children Undergoing MRI
Interventions
- DRUG
-
Melatonin 3 MG
Oral syrup melatonin 3 mg
- DRUG
-
Chloral Hydrate
Oral chloral hydrate (50 mg/kg, maximum 2 g)
- DRUG
-
Sevoflurane
Inhalational Sevoflurane
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-20
- Primary Completion
- 2024-12-30
- Completion
- 2024-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging
NCT03806777 ·Status: UNKNOWN ·Phase: PHASE4
-
Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
NCT03220880 ·Status: COMPLETED
-
The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study
NCT01855581 ·Status: UNKNOWN
-
Thiopental Versus Propofol During Magnetic Resonance Imagining in Children: Something Old, Something New
NCT01318044 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intranasal Dexmedetomidine Sedation at Dose of 2 mcg/kg Versus 4 mcg/kg in Children Undergoing MRI
NCT05091151 ·Status: COMPLETED ·Phase: NA
-
The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Prospective Study
NCT01855555 ·Status: COMPLETED
-
Effects of Propofol and Ketofol on Core Body Temperature in MRI
NCT02931786 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine Sedation in Children Before MRI Examinations
NCT05163704 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine Sedation in Children With Respiratory Morbidities
NCT02555605 ·Status: COMPLETED
-
Dose of Remi in Children
NCT05990673 ·Status: UNKNOWN ·Phase: NA
-
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
NCT06061159 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia
NCT02481791 ·Status: UNKNOWN ·Phase: PHASE3
-
Non-operating Room Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases
NCT05423821 ·Status: UNKNOWN
-
A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine
NCT03806595 ·Status: COMPLETED ·Phase: PHASE1
-
Sedation Versus Protective Stabilization for Pediatric Dental Treatment
NCT04119180 ·Status: RECRUITING ·Phase: PHASE4
-
Remifentanil in Children With Obstructive Sleep Apnea
NCT03958396 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children
NCT02402868 ·Status: COMPLETED ·Phase: PHASE3
-
ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children
NCT06121609 ·Status: COMPLETED ·Phase: NA
-
Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions
NCT02512055 ·Status: COMPLETED ·Phase: PHASE4
-
ED50 of Esketamine for Laser Treatment in Children
NCT06294639 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Optimizing Pain Treatment in Children On Mechanical Ventilation
NCT06994442 ·Status: RECRUITING ·Phase: PHASE3
-
Chloral Hydrate to Perform Auditory Brainstem Response (ABR)
NCT00949780 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of Oral Midazolam Plus Oral Ketamine for Sedation During Laceration Repair
NCT01470157 ·Status: UNKNOWN ·Phase: PHASE4
-
Anesthesia Related Neurocognitive Deficits in Children
NCT03034889 ·Status: COMPLETED
-
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
NCT04499755 ·Status: RECRUITING ·Phase: PHASE3